1.

Assertive Community Treatment in the Netherlands: Outcome and Model Fidelity

1.

How more data reinforces evidence-based transport policy in the Short and Long-Term: Evaluating a policy pilot in two Dutch cities

1.

A survey of tax compliance costs of Flemish SMEs: magnitude and determinants

1.

Evidence-based policy making: how cost-effective are disease management programs in the Netherlands?

2.

Evidence-based policy making: how cost-effective are disease management programs in the Netherlands?

3.

Evidence-based policy making: how cost-effective are disease management programs in the Netherlands?

4.

Evidence-based policy making: how cost-effective are disease management programs in the Netherlands?

5.

Evidence-based policy making: how cost-effective are disease management programs in the Netherlands?

6.

Evidence-based policy making: how cost-effective are disease management programs in the Netherlands?

1.

Early Childhood Education Intervention Programs in the Netherlands: Still Searching for Empirical Evidence

2.

Early Childhood Education Intervention Programs in the Netherlands: Still Searching for Empirical Evidence

3.

Early Childhood Education Intervention Programs in the Netherlands: Still Searching for Empirical Evidence

1.

Effectiveness and Safety of Ibrutinib for Chronic Lymphocytic Leukemia in Routine Clinical Practice: 3-Year Follow-up of the Belgian Ibrutinib Real-World Data (BiRD) Study

2.

Effectiveness and Safety of Ibrutinib for Chronic Lymphocytic Leukemia in Routine Clinical Practice: 3-Year Follow-up of the Belgian Ibrutinib Real-World Data (BiRD) Study

3.

Effectiveness and Safety of Ibrutinib for Chronic Lymphocytic Leukemia in Routine Clinical Practice: 3-Year Follow-up of the Belgian Ibrutinib Real-World Data (BiRD) Study

4.

Effectiveness and Safety of Ibrutinib for Chronic Lymphocytic Leukemia in Routine Clinical Practice: 3-Year Follow-up of the Belgian Ibrutinib Real-World Data (BiRD) Study

5.

Effectiveness and Safety of Ibrutinib for Chronic Lymphocytic Leukemia in Routine Clinical Practice: 3-Year Follow-up of the Belgian Ibrutinib Real-World Data (BiRD) Study

6.

Effectiveness and Safety of Ibrutinib for Chronic Lymphocytic Leukemia in Routine Clinical Practice: 3-Year Follow-up of the Belgian Ibrutinib Real-World Data (BiRD) Study

7.

Effectiveness and Safety of Ibrutinib for Chronic Lymphocytic Leukemia in Routine Clinical Practice: 3-Year Follow-up of the Belgian Ibrutinib Real-World Data (BiRD) Study

1.

After Zigzagging Between Extremes, Finally Common Sense? Will Belgium Return to Reasonable Rules on Illegally Obtained Evidence?

1.

Pediatric Sedation in Dutch Dental Clinics: The Influence of Guideline Modifications on Adverse Events

1.

'Healthy children in sound communities' (HCSC/gkgk)--a Dutch-German community-based network project to counteract obesity and physical inactivity

1.

Translating the SLIM diabetes prevention intervention into SLIMMER: implications for the Dutch primary health care